The AAP has issued interim guidance supporting early rather than delayed peanut introduction during the period of complementary food introduction in infants.
The benefit of sublingual immunotherapy (SLIT) over placebo for seasonal grass pollen allergies appears to be small.
About 15% of children who have a severe allergic reaction can have a second one within a few hours.
The case of an 8-year-old Canadian boy suggests that it's possible, but still rare, for children to develop food allergies from blood transfusions.
Aimmune Therapeutics announced that the Phase 2 study of a novel investigational oral immunotherapy (AR101) for the treatment of peanut allergy met its primary endpoint of tolerating a cumulative amount of peanut protein of at least 443mg.
A new blood test may be able to predict who will have severe allergic reactions to foods.
Experts are predicting that this allergy season may be one of the worst in years.
The FDA is recommending that manufacturers stop using the labels “latex-free” or “does not contain latex” due to the scientific inaccuracy of these claims.